PP
TWST icon

Paloma Partners’s Twist Bioscience TWST Stock Holding History

Paloma Partners’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,930
Closed -$243K – 1685
2024
Q2 		$243K Buy
+4,930
New +$201K 0.01% 953

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paloma Partners's TWST Position: Q3 2024 in Review

Paloma Partners sold out of Twist Bioscience (TWST) in Q3 2024, closing a stake of 4,930 shares — an estimated $243K sold.

Paloma Partners first reported a position in TWST in Q2 2024 and held it in 1 quarter. The position peaked at $243K in Q2 2024. 245 funds tracked by Wall St. Rank hold TWST as of Q3 2024.

  • Paloma Partners reported no remaining Twist Bioscience position as of Q3 2024 after selling out during the quarter.
  • Paloma Partners sold 4,930 Twist Bioscience shares in Q3 2024, an estimated $243K.
  • Paloma Partners first reported a position in Twist Bioscience in Q2 2024 and held it in 1 quarter.
  • Paloma Partners's Twist Bioscience position peaked at $243K in Q2 2024.
  • 245 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.

Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.